GP6 and ischemic stroke: Data from patients and animal models confirm that the absence of GP VI protects against thrombosis without causing severe spontaneous haemorrhages, which has sparked interest in developing and evaluating anti-GP VI drugs as a new antithrombotic therapy, especially in ischaemic stroke [35].